ethosuximide

Generic: ethosuximide

Labeler: pai holdings, llc dba pai pharma
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ethosuximide
Generic Name ethosuximide
Labeler pai holdings, llc dba pai pharma
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

ethosuximide 250 mg/5mL

Manufacturer
PAI Holdings, LLC dba PAI Pharma

Identifiers & Regulatory

Product NDC 0121-0670
Product ID 0121-0670_14d8b71e-abd8-49d4-b4cc-82880e54db8c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA040253
Listing Expiration 2026-12-31
Marketing Start 2000-11-22

Pharmacologic Class

Established (EPC)
anti-epileptic agent [epc]
Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01210670
Hyphenated Format 0121-0670

Supplemental Identifiers

RxCUI
251322
UPC
0301210670169
UNII
5SEH9X1D1D
NUI
N0000175753 N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ethosuximide (source: ndc)
Generic Name ethosuximide (source: ndc)
Application Number ANDA040253 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/5mL
source: ndc
Packaging
  • 473 mL in 1 BOTTLE (0121-0670-16)
source: ndc

Packages (1)

0121-0670-16 473 mL in 1 BOTTLE (0121-0670-16)

Ingredients (1)

ethosuximide (250 mg/5mL)

Linked Drug Pages (1)

ETHOSUXIMIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "14d8b71e-abd8-49d4-b4cc-82880e54db8c", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0301210670169"], "unii": ["5SEH9X1D1D"], "rxcui": ["251322"], "spl_set_id": ["8a5cc930-0b36-48a8-9ad0-de633b208742"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["PAI Holdings, LLC dba PAI Pharma"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (0121-0670-16)", "package_ndc": "0121-0670-16", "marketing_start_date": "20001122"}], "brand_name": "ETHOSUXIMIDE", "product_id": "0121-0670_14d8b71e-abd8-49d4-b4cc-82880e54db8c", "dosage_form": "SOLUTION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0121-0670", "generic_name": "ETHOSUXIMIDE", "labeler_name": "PAI Holdings, LLC dba PAI Pharma", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ETHOSUXIMIDE", "active_ingredients": [{"name": "ETHOSUXIMIDE", "strength": "250 mg/5mL"}], "application_number": "ANDA040253", "marketing_category": "ANDA", "marketing_start_date": "20001122", "listing_expiration_date": "20261231"}